RespireRx Pharmaceuticals Inc. Quarterly Interest Expense in USD from Q3 2011 to Q3 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
RespireRx Pharmaceuticals Inc. quarterly/annual Interest Expense history and growth rate from Q3 2011 to Q3 2023.
  • RespireRx Pharmaceuticals Inc. Interest Expense for the quarter ending September 30, 2023 was $73.4K, a 22.4% decline year-over-year.
  • RespireRx Pharmaceuticals Inc. Interest Expense for the twelve months ending September 30, 2023 was $436K, a 45.5% decline year-over-year.
  • RespireRx Pharmaceuticals Inc. annual Interest Expense for 2022 was $604K, a 16.7% decline from 2021.
  • RespireRx Pharmaceuticals Inc. annual Interest Expense for 2021 was $725K, a 32.8% increase from 2020.
  • RespireRx Pharmaceuticals Inc. annual Interest Expense for 2020 was $546K, a 34.8% increase from 2019.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Quarterly (USD)
Interest Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2023 $436K $73.4K -$21.2K -22.4% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-17
Q2 2023 $457K $225K +$45.5K +25.4% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-21
Q1 2023 $411K $67.3K -$192K -74.1% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-22
Q4 2022 $604K $70K -$195K -73.6% Oct 1, 2022 Dec 31, 2022 10-K 2023-04-17
Q3 2022 $799K $94.6K -$134K -58.5% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-17
Q2 2022 $933K $180K +$27.7K +18.2% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-21
Q1 2022 $905K $260K +$180K +227% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-22
Q4 2021 $725K $265K +$130K +95.5% Oct 1, 2021 Dec 31, 2021 10-K 2023-04-17
Q3 2021 $595K $228K +$150K +190% Jul 1, 2021 Sep 30, 2021 10-Q 2021-11-15
Q2 2021 $446K $152K -$38.8K -20.3% Apr 1, 2021 Jun 30, 2021 10-Q 2021-08-16
Q1 2021 $484K $79.5K -$61.2K -43.5% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-23
Q4 2020 $546K $136K -$47.2K -25.8% Oct 1, 2020 Dec 31, 2020 10-K 2022-04-15
Q3 2020 $593K $78.7K +$8.51K +12.1% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15
Q2 2020 $584K $191K +$120K +170% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-16
Q1 2020 $464K $141K +$59.6K +73.5% Jan 1, 2020 Mar 31, 2020 10-Q 2020-05-20
Q4 2019 $405K $183K +$143K +357% Oct 1, 2019 Dec 31, 2019 10-K 2021-04-15
Q3 2019 $262K $70.2K +$35K +99.6% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-23
Q2 2019 $227K $70.5K +$36.7K +109% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-19
Q1 2019 $190K $81.1K +$53.8K +197% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-20
Q4 2018 $136K $40K +$15.5K +63% Oct 1, 2018 Dec 31, 2018 10-K 2020-04-14
Q3 2018 $121K $35.2K +$8.81K +33.4% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-19
Q2 2018 $112K $33.8K +$7.51K +28.6% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-14
Q1 2018 $104K $27.3K +$2.24K +8.93% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-20
Q4 2017 $102K $24.6K +$258 +1.06% Oct 1, 2017 Dec 31, 2017 10-K 2019-04-16
Q3 2017 $102K $26.4K -$89.5K -77.3% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-16
Q2 2017 $191K $26.3K -$173K -86.8% Apr 1, 2017 Jun 30, 2017 10-Q 2018-10-15
Q1 2017 $365K $25K -$222K -89.9% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-21
Q4 2016 $586K $24.3K -$127K -84% Oct 1, 2016 Dec 31, 2016 10-K 2018-04-17
Q3 2016 $714K $116K -$137K -54.2% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-20
Q2 2016 $851K $199K -$70K -26% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-14
Q1 2016 $921K $247K +$18.2K +7.98% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-19
Q4 2015 $903K $152K +$73.5K +94% Oct 1, 2015 Dec 31, 2015 10-K 2017-03-31
Q3 2015 $829K $253K +$240K +1854% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-15
Q2 2015 $589K $269K +$256K +1950% Apr 1, 2015 Jun 30, 2015 10-Q/A 2016-08-12
Q1 2015 $333K $229K +$215K +1650% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-13
Q4 2014 $117K $78.2K +$64.8K +487% Oct 1, 2014 Dec 31, 2014 10-K 2016-03-29
Q3 2014 $52.5K $13K -$352 -2.65% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-12
Q2 2014 $52.8K $13.1K -$1.54K -10.5% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-13
Q1 2014 $54.4K $13.1K -$1.98K -13.1% Jan 1, 2014 Mar 31, 2014 10-Q/A 2015-08-07
Q4 2013 $56.3K $13.3K -$76.2K -85.1% Oct 1, 2013 Dec 31, 2013 10-K 2015-03-30
Q3 2013 $133K $13.3K -$85.2K -86.5% Jul 1, 2013 Sep 30, 2013 10-Q 2015-03-09
Q2 2013 $218K $14.7K +$6.8K +86.2% Apr 1, 2013 Jun 30, 2013 10-Q 2015-02-24
Q1 2013 $211K $15K +$14K +1396% Jan 1, 2013 Mar 31, 2013 10-Q 2015-02-10
Q4 2012 $197K $89.5K Oct 1, 2012 Dec 31, 2012 10-K 2015-01-06
Q3 2012 $98.6K +$97.5K +9706% Jul 1, 2012 Sep 30, 2012 10-Q 2014-12-15
Q2 2012 $7.89K Apr 1, 2012 Jun 30, 2012 10-Q 2014-12-15
Q1 2012 $1.01K Jan 1, 2012 Mar 31, 2012 10-Q 2014-11-24
Q3 2011 $1.01K Jul 1, 2011 Sep 30, 2011 10-Q 2014-07-30
* An asterisk sign (*) next to the value indicates that the value is likely invalid.